Back in 2021, at the height of the pandemic, scientists at Pfizer revealed the development of a novel antiviral molecule, ...

Medicare beneficiaries can get Paxlovid for free through the U.S. Government Patient Assistance Program (USG PAP) until December 31, 2025. Read more.

An alternative to Paxlovid, the only antiviral pills approved by the US Food and Drug Administration to treat COVID-19, is on ...

A new study suggests Paxlovid may not reduce the risk of covid-19 hospitalizations and all-cause deaths in vaccinated adults ages 65 to 74.

CVH-174 bioavailability enhanced by ritonavir and zosuquidar March 4, 2025 Since its identification more than 50 years ago, pleuromutilin has served as a scaffold for the development of new types of ...

Sotrovimab was effective against Omicron B.1.1.529/BA.1 subvariants and nirmatrelvir/ritonavir was effective against Omicron BA.2/BA.4/BA.5 subvariants. Certain antiviral drugs and monoclonal antibody ...

Antiretroviral drugs are used to treat HIV infection. They work by blocking a stage of the virus's life cycle and, by doing so, prevent the virus from replicating. The drugs are organized into six ...

Paxlovid—a combination of nirmatrelvir tablets and ritonavir—is the first oral antiviral pill to be approved by the Food and Drug Administration for the treatment of mild to moderate COVID-19 in ...